Close Menu

Colorectal Cancer

News and reporting on colorectal cancer.

Citing the FDA's handling of KRAS testing for anti-EGFR monoclonal antibodies, the report asserts that in the near term complex genetic tests such as Oncotype DX should be "performed through CLIA labs, and not held up by slow regulatory processes."

Snippets: Apr 1, 2009

Premium

Epigenomics, Response Genetics, Exact Sciences

A group of researchers from Israel and the US report that they have characterized chromosomal abnormalities in different colorectal cancer stages and identified alterations associated with poor outcomes.

The company said that developing the test would be its priority in 2009, putting it on a somewhat accelerated development schedule. Rosetta had originally said the test might not be available until 2010.

New Releases: Mar 25, 2009

Premium

DxS' TheraScreen KRAS Mutation Kit

DxS get EU approval to sell its TheraScreen K-RAS Mutation Kit for use on Roche's LightCycler instrument and licensed rights to related software.

In opening its new translational research lab, Mass General claims to be "the first and only cancer center" to attempt to molecularly profile all cancer patients that present to the facility.

The hospital will use a new lab to study tumors and to try to develop individual treatments.

Called Proactive, the consortium will use the funds to build out Olink Bioscience's proximity ligation assays to improve the detection of biomarkers for colorectal cancer in plasma.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.